↑: Increased with regard to normal levels; ↓: Decreased with regard to normal levels; CTL: Cytotoxic T lymphocyte; MDS: Myelodysplastic syndrome.

If you’ve just found out you have myelodysplastic syndrome (MDS), you’ll surely have lots of questions. You may never have heard of MDS before or known anyone who had it. You may feel a wide ...

If you have MDS, a type of blood cancer called myelodysplastic syndrome, you’re part of a rare group of people with the diagnosis. But research is ongoing. Many clinical trials are seeking new ...

This year’s most-viewed articles and videos on myelodysplastic syndromes (MDS) explored patient quality of life, risk factors ...

As a survivor of MDS, I’ve learned to make the best of every day and to be thankful for life. Sometimes this means avoiding ...

Anthony Olson was diagnosed with Myelodysplastic syndromes (MDS) and went on to receive chemo for almost a decade to treat ...

Practical considerations for managing patient adherence on an oral therapy for higher-risk myelodysplastic syndromes.

NEXI-001 is under clinical development by NexImmune and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase II drugs for Myelodysplastic Syndrome have a 30% phase ...

Smokers with myelodysplastic syndromes (MDS) or a precursor condition had elevated levels of genetic mutations linked to the disease, a new study shows. The study also found that heavier smokers ...

Zilurgisertib fumarate is under clinical development by Incyte and currently in Phase II for Myelodysplastic Syndrome.

↑: Increased with regard to normal levels; ↓: Decreased with regard to normal levels; CTL: Cytotoxic T lymphocyte; MDS: Myelodysplastic syndrome.